DV
DVLP.US Golden Developing Solutions Inc
- Market cap
- USD 141K
- P/E
- -
- P/B
- 4.18x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is DVLP.US undervalued?
Graham numberThe Graham number of Golden Developing Solutions Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Golden Developing Solutions Inc fundamental analysis
No fundamental analysis for Golden Developing Solutions Inc yet.
Golden Developing Solutions Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Golden Developing Solutions Inc
Golden Developing Solutions, Inc. operates as online health and wellness holding company. It specializes in providing specialty medicine with rapid delivery services and medical support in the United States. The company was formerly known as Clean Hydrogen Producers, Ltd and changed its name to Golden Developing Solutions, Inc. in April 2017. Golden Developing Solutions, Inc. was founded in 1998 and is based in Fort Lauderdale, Florida. On August 7, 2024, the voluntary petit…
Full company profileGolden Developing Solutions Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Golden Developing Solutions Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 1.30M | 1.32M | - | 266K | - | - | 0.00 | 0.00 | 2.58M |
| Gross Profit | 353K | 266K | - | -12.2K | - | -175K | -72.5K | 0.00 | 1.18M |
| Operating Income | 17.9K | -119K | -29.2K | -1.02M | - | -1.56M | -346K | -2.38M | -496K |
| EBITDA | - | - | - | -1.02M | - | -1.38M | -365K | -2.38M | - |
| Net Income | 17.9K | -103K | -32.9K | -1.60M | - | -8.98M | -630K | -1.41M | -6.42M |
| EPS | - | - | 0.00 | -0.01 | - | -0.01 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||
| Total Assets | 35.2K | 46.7K | - | 8.98M | - | 5.63M | 10.7K | 8.71M | 7.92M |
| Total Liabilities | 300.00 | 700.00 | 26.5K | 4.02M | - | 5.31M | 998K | 6.67M | 9.20M |
| Shareholders' Equity | 34.9K | 46.0K | - | 4.96M | - | 367K | -987K | 2.04M | -1.27M |
| Cash & Short-term Investments | 22.8K | 29.4K | - | 12.5K | - | 104K | 10.7K | 210K | 323K |
| Total Debt | - | - | - | - | - | 1.22M | 577K | 6.51M | 383K |
| Cash Flow | |||||||||
| Operating Cash Flow | -2.48K | 6.60K | -700K | -700K | -862K | -862K | -136K | 183K | 71.2K |
| Capital Expenditure | 0.00 | 0.00 | 12.1K | 12.1K | 75.0K | 75.0K | 0.00 | 5.00 | 1.08M |
| Free Cash Flow | - | - | - | - | - | -937K | -136K | 183K | -1.01M |
| Ratios | |||||||||
| ROE | 51.1% | -223.3% | - | -32.2% | - | -2,447.0% | - | -69.1% | - |
| ROA | 50.7% | -219.9% | - | -17.8% | - | -159.6% | -5,868.7% | -16.2% | -81.0% |
| Net Profit Margin | 1.4% | -7.8% | - | -600.7% | - | - | - | - | -248.9% |
| Debt to Equity | - | - | - | - | - | 3.31x | - | 3.19x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Golden Developing Solutions Inc dividends
Golden Developing Solutions Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:6 on Jun 12, 2007.
Who owns Golden Developing Solutions Inc
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 1.41B
- Free float 1.41B
Golden Developing Solutions Inc company profile
- Company name
- Golden Developing Solutions Inc
- Ticker
- DVLP.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- PO Box 460573, Fort Lauderdale, FL, United States, 33346
- Phone
- 623 826 5206
- Website
- goldendeveloping.com
About Golden Developing Solutions Inc
Golden Developing Solutions, Inc. operates as online health and wellness holding company. It specializes in providing specialty medicine with rapid delivery services and medical support in the United States. The company was formerly known as Clean Hydrogen Producers, Ltd and changed its name to Golden Developing Solutions, Inc. in April 2017. Golden Developing Solutions, Inc. was founded in 1998 and is based in Fort Lauderdale, Florida. On August 7, 2024, the voluntary petition of Golden Developing Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliate on June 22, 2023.
Golden Developing Solutions Inc management
2- Mr. Stavros A. TriantPresident, CEO, CFO, Secretary, Treasurer & Chairman · born 1977
- Dr. Harald WirthChief Operating Officer · born 1961